DIANA REIMANN: Open Payments
NPI 1508849688 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$175 in 9 payments from 8 companies in 2025. Trend: 2023 $184 · 2024 $106 · 2025 $175
Food & beverage: $175
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $35 |
| Madrigal Pharmaceuticals | 1 | $27 |
| Lilly USA, LLC | 1 | $22 |
| Abbott Laboratories | 1 | $22 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $15 |
| Antares Pharma, Inc. | 1 | $15 |
Products named: JARDIANCE, REZDIFFRA, FREESTYLE LIBRE 3, AUSTEDO XR, Kerendia, XIFAXAN, XYOSTED.
Industry payments across TX — which companies pay providers there.
